ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
202.93
+0.2900
0.14%
盤後：
203.02
0.0900
+0.04%
19:37 EDT
成交量：
228.63萬
成交額：
4.65億
市值：
102.78億
市盈率：
32.15
高：
205.31
開：
203.94
低：
202.75
收：
202.64
52周最高：
217.12
52周最低：
138.79
股本：
5,065.00萬
流通股本：
5,065.00萬
量比：
1.60
換手率：
4.51%
股息：
0.41
股息率：
0.20%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率：
24.54%
總資產收益率：
0.10%
市淨率：
1.26
市盈率(LYR):
-135.83
資料載入中...
總覽
公司
新聞
公告
創新藥研發加速遇「猴荒」
三里河
·
07/22
吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒
路透中文
·
07/22
安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解
路透中文
·
07/21
Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元
美股速递
·
07/21
Leerink下調吉利德科學目標價至127美元
格隆汇
·
07/21
Kalshi將允許對臨床試驗和FDA決定進行投注
路透中文
·
07/16
三星生物製劑與歐加農將在澳大利亞推出新型生物類似藥。
智通财经
·
07/16
剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗
路透中文
·
07/14
Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局
金吾财讯
·
07/13
Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事會
投资观察
·
07/13
RBC將Kymera Therapeutics的評級下調至「與行業持平」，並上調目標價
路透中文
·
07/13
英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作
新浪港股
·
07/13
福泰製藥百億美元併購透露了什麼訊號？
蓝鲸财经
·
07/11
吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉
TradingKey中文
·
07/11
BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet
路透中文
·
07/10
滙豐表示，生物製藥領域的併購交易有望創下年度新高
路透中文
·
07/10
福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息
TradingKey中文
·
07/09
大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間
智通财经
·
07/08
復宏漢霖(02696)：西妥昔單抗注射液生物類似藥HLX05-N在轉移性結直腸癌(mCRC)患者中的1期臨床研究於中國境內完成首例患者給藥
智通财经
·
07/08
RBC Capital上調福泰製藥目標價至570美元
格隆汇
·
07/08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/IBB/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202.93,"timestamp":1789156800000,"preClose":202.64,"halted":0,"volume":2286306,"hourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"delay":0,"changeRate":0.0014311093564943766,"floatShares":50650000,"shares":50650000,"eps":6.311863,"marketStatus":"休市中","change":0.29,"latestTime":"09-11 16:00:00 EDT","open":203.94,"high":205.31,"low":202.75,"amount":465174036.47682,"amplitude":0.012633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202.64,"sharesOutstanding":49450000,"nav":202.867176,"aum":10356369334.8,"dividendRate":0.001997,"bidAskSpread":0.000338,"preHourTrading":{"tag":"盘前","latestPrice":204.63,"preClose":202.64,"latestTime":"09:25 EDT","volume":602,"amount":123106.38130000001,"timestamp":1789133112066,"change":1.99,"changeRate":0.00982,"amplitude":0.017917},"postHourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"volumeRatio":1.6013834487935477,"impliedVol":0.2368,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50650000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.6013834487935477,"shares":50650000,"dividePrice":0.4053,"high":205.31,"amplitude":0.012633,"preClose":202.64,"low":202.75,"week52Low":138.785,"pbRate":"1.26","psRate":"247.29","week52High":217.12,"institutionHeld":0,"latestPrice":202.93,"eps":6.311863,"divideRate":0.001997,"volume":2286306,"delay":0,"ttmEps":6.311863,"open":203.94,"prevYearClose":168.77,"prevWeekClose":211.92,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":213.81,"twentyDayClose":198.94,"sixtyDayClose":171.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653584157","title":"創新藥研發加速遇「猴荒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SBIO","BIOY","LFSC","WRND","XLVI","GSKH","APXH","BK4585","BK4588","IBB","BBP","GDOC","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","JDOC","LU1929549753.HKD","BMED","LU2023250843.SGD","LU1778281490.HKD","IBB","HRTS","BIB","LU1941712348.USD","FHLC","GDOC","FTXH","LU0889565916.HKD","RXL","TMED","SG9999001176.USD","LU1989771016.USD","LU0058720904.USD","LU1923622614.USD","LU2087621335.USD","LU2089984988.USD","LU1066053197.SGD","LU0432979614.USD","IHE","MRK","LU0868494708.USD","PAWZ","XLV","LU0266013472.USD","PPH","GILD","IE00BJJMRZ35.SGD","LU2324357040.USD","IXJ","MEDI","LU1983299246.USD","BBH","LU1023059063.AUD","SG9999015952.SGD","LU1291159041.SGD","VHT","LU1093756168.USD","SG9999014542.SGD","TRUH","IBBQ","LU0861579265.USD","IYH","TBXU","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4533","LU1061106388.HKD","IBB","LU1023059063.AUD","LU1983299246.USD","LU0320765992.SGD","BK4581","BK4588","BK4585","IBBQ","LU2089984988.USD","IE0002141913.USD","IE00B4R5TH58.HKD","TBXU","LU0289739699.SGD","IE00B2B36J28.USD","LU1571399168.USD","BK4599","SG9999001440.SGD","LU2242646821.SGD","LU0109394709.USD","LU0889565916.HKD","BBH","LU2112291526.USD","PBE","BIB","LU0058720904.USD","LU2242652126.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","PJP","BK4534","LU2468319806.SGD","AMGN","IE0009355771.USD","BK4139","LU0868494617.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","IBB","IE0002270589.USD","MEDI","LU1934455194.USD","SG9999015952.SGD","GILD","LU1061106388.HKD","LU1934455863.HKD","BK4532","LU1023059063.AUD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU0965509101.SGD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0965508806.USD","LU0861579265.USD","BK4583","LU1037948897.HKD","LU0882574055.USD","TBXU","LU0320765992.SGD","LU1430594728.SGD","LU0965509283.SGD","LU0289739699.SGD","LU0109394709.USD","LU1037948541.HKD","SG9999015978.USD","LU0965509010.AUD","LU0889565916.HKD","IE00B19Z3581.USD","LU0234570918.USD","LU1934455277.USD","SG9999015986.USD","BK4139","BMED","LU0114720955.EUR","BK4585","LU1066053197.SGD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU1778281490.HKD","BK4566","LU2468319806.SGD","LU1674673428.USD","IE00B3T34201.USD","LU2112291526.USD","LU1674673691.USD","BK4578","LU1066051498.USD","BIB","LU2089984988.USD","LU0823416689.USD","IBBQ","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4568","LU1839511570.USD","LU1571399168.USD","BBH","SG9999015945.SGD","TMED","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下調吉利德科學目標價至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653210240?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","LU0058720904.USD","LU0234570918.USD","SG9999015986.USD","UUP","LU0109394709.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU2089984988.USD","SG9999015945.SGD","GILD","LU0965509283.SGD","BMED","IE00BSNM7G36.USD","MEDI","LU1674673691.USD","BK4139","SG9999015978.USD","LU0823416689.USD","BK4585","LU2112291526.USD","LU1066053197.SGD","LU0122379950.USD","UDN","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU2468319806.SGD","LU0320765992.SGD","LU2087621335.USD","LU0965509010.AUD","LU1674673428.USD","BK4550","IE00BKVL7J92.USD","LU0882574055.USD","IBBQ","LU0289739699.SGD","BK4583","LU0861579265.USD","LU1778281490.HKD","LU1023059063.AUD","LU2324357040.USD","LU1934455863.HKD","LU1839511570.USD","LU1585245621.USD","IBB","BK4578","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423028","title":"Kalshi將允許對臨床試驗和FDA決定進行投注","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423028","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652423028?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 23:59","pubTimestamp":1784217550,"startTime":"0","endTime":"0","summary":"Kalshi将允许对临床试验和FDA决定进行投注路透7月16日-预测市场平台Kalshi周四表示，将开始接受针对临床试验结果和美国食品药品监督管理局监管审查结果的投注，这标志着药物研发的赔率首次向公众公开。Kalshi表示，这些市场允许投资者针对单一药物而非整个公司进行投注。Kalshi和AppliedXL将在试验完成受试者招募后才发布相关合约。Kalshi平台于2021年上线，允许用户对体育赛事、选举结果和天气等事件进行投注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0114720955.EUR","BK4566","LU0122379950.USD","SG9999015978.USD","LU1674673428.USD","LU2468319806.SGD","BMED","LU0861579265.USD","BK4578","GILD","IE00B19Z3B42.SGD","BK4585","IBBQ","LU1934455277.USD","LU1066051498.USD","LU1934455863.HKD","SG9999015952.SGD","IBB","LU0965508806.USD","SMMT","BK4588","SG9999015945.SGD","LU1057294990.SGD","LU2324357040.USD","BK4583","IE0002270589.USD","LU1674673691.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU2087621335.USD","LU0109394709.USD","BK4532","BBH","LU1037948541.HKD","LU1061106388.HKD","LU0058720904.USD","BIB","LU2089984988.USD","LU1839511570.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU0823416689.USD","LU0882574055.USD","LU0965509283.SGD","LU2112291526.USD","LU0234570918.USD","LU1585245621.USD","LU1037948897.HKD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495621","title":"三星生物製劑與歐加農將在澳大利亞推出新型生物類似藥。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495621","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651495621?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 04:04","pubTimestamp":1784145897,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2322448791.USD","BK4588","IBB","IE00B5TLWC47.USD","EMXC","LU2272731865.HKD","LU2272731782.SGD","PPH","LU1992135472.HKD","XPH","LU1992135399.USD","LU2322448957.HKD","LU2272731600.USD","LU2473716301.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105068","title":"剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105068?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 20:47","pubTimestamp":1784033246,"startTime":"0","endTime":"0","summary":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验路透7月14日-刚果民主共和国的研究人员周二表示，他们已开始招募受试者，参与一项临床试验，测试吉利德科学公司GILD.O旗下实验性抗病毒药物奥贝德西韦作为刚果和乌干达当前邦迪布吉奥埃博拉疫情的暴露后治疗药物。在临床前研究中，奥贝德西韦已显示出对丝状病毒的活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4S43G1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0861579265.USD","LU1778281490.HKD","BK4585","IE00B3T34201.USD","LU0965508806.USD","LU1674673691.USD","LU1934455277.USD","BIB","BK4550","LU1057294990.SGD","SG9999015986.USD","LU1934455863.HKD","LU2087621335.USD","BMED","IE00B19Z3B42.SGD","LU1571399168.USD","BK4583","IBB","LU0289739699.SGD","LU1061106388.HKD","LU1585245621.USD","LU1066053197.SGD","MEDI","LU0965509283.SGD","LU1023059063.AUD","LU2468319806.SGD","BK4566","LU0320765992.SGD","LU0114720955.EUR","SG9999015978.USD","LU2089984988.USD","LU2324357040.USD","LU0965509010.AUD","BBH","LU1934455194.USD","IBBQ","IE0002270589.USD","BK4588","LU1037948897.HKD","IE00B7SZLL34.SGD","BK4532","LU0234570918.USD","IE00BSNM7G36.USD","GILD","LU1430594728.SGD","LU1839511570.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117599?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals 与 Crinetics Pharmaceuticals 共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","LU0566484027.USD","LU1674673428.USD","LU2237438978.USD","LU2362541273.HKD","IE0002270589.USD","IE0002141913.USD","LU1585245621.USD","VRTX","BK4007","CRNX","BBH","LU0889565916.HKD","IE00B894F039.SGD","LU0757428866.USD","LU1093756325.SGD","BK4585","IBB","LU0109394709.USD","LU1069344957.HKD","LU2456880835.USD","SG9999001176.SGD","IE00BFTCPJ56.SGD","VERX","IE0009355771.USD","SG9999001176.USD","SG9999013999.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2417539215.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU2462157665.USD","IE00BZ9MQY76.HKD","LU1093756168.USD","IE00B2B36J28.USD","BIB","LU0079474960.USD","IE00B19Z9Z06.USD","IBBQ","LU0256863811.USD","LU0432979614.USD","BK4532","LU2362540622.SGD","LU1035775433.USD","LU0234570918.USD","PBE","BK4588","IDNA","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183275253","title":"Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1183275253","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183275253?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:35","pubTimestamp":1783946106,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Pliant Therapeutics今日宣布，任命Flavia Borellini博士与Robert Iannone博士为公司董事会新成员。这两项任命为董事会注入了深厚的全球肿瘤药物开发经验，并进一步强化了其在运营与监管事务方面的专业能力。目前，除了在Pliant任职外，他还担任Autolus Therapeutics的董事会成员。关于Pliant Therapeutics, Inc.：Pliant Therapeutics是一家临床阶段的生物制药公司，专注于基于整合素的疗法的发现与开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4232","LENZ","R","BK4585","BK4588","IBB","BK4539","BK4139","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711531","title":"RBC將Kymera Therapeutics的評級下調至「與行業持平」，並上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711531","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651711531?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 18:52","pubTimestamp":1783939974,"startTime":"0","endTime":"0","summary":"BUZZ-RBC将Kymera Therapeutics的评级下调至“与行业持平”，并上调目标价7月13日-** RBC资本市场将Kymera Therapeutics（KYMR.O）的评级从“跑赢大盘”下调至“与行业持平”，同时将其目标价从106美元上调至115美元** RBC表示，Kymera的KT-621是一种用于治疗中重度嗜酸性粒细胞性哮喘的每日一次实验性口服药，其在临床终点和生物标志物方","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4T43F0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2106854487.HKD","LU1917777945.USD","LU2362541513.USD","LU0053666078.USD","BBH","LU0058720904.USD","LU2468319806.SGD","LU0289739699.SGD","LU1974910355.USD","REGN","LU0823434583.USD","BK4139","LU2237438978.USD","LU0114720955.EUR","LU2362541273.HKD","LU0882574055.USD","BK4585","BK4588","LU0823434740.USD","IBBQ","LU2362540622.SGD","LU0823416689.USD","LU0320765992.SGD","IBB","LU2023250504.SGD","LU0109394709.USD","KYMR","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162210","title":"英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162210?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 10:02","pubTimestamp":1783908120,"startTime":"0","endTime":"0","summary":" 英硅智能早盘涨超7%，截至发稿，股价上涨6.21%，报45.48港元，成交额3.32亿港元。 7月13日，据英硅智能官微消息，公司宣布与康哲药业在中枢神经系统领域开展另一项AI驱动的药物发现合作。 根据合作协议，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，双方共同推进该研发项目的合作开发。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00867","SG9999015945.SGD","IE00BMCWC346.EUR","GSKH","BK1593","VTHR","IE00BYV24P56.USD","ARTY","SG9999015952.SGD","IE00BVYPNQ40.USD","BK4588","PBE","SG9999015986.USD","GDOC","BBP","WRND","SG9999015978.USD","IBB","AIPO","IE00BVYPNP33.GBP","LFSC","BK4585","LU2488822045.USD","CHAT","BK1191","AGIX","SG9999004220.SGD","SBIO","QTOC","IE00BGHQDM52.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰製藥百億美元併購透露了什麼訊號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650760159?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IE00B894F039.SGD","BIB","LU0109394709.USD","LU2236285917.USD","IE00BFTCPJ56.SGD","XMMO","MYLD","BK4139","PBE","IE0002141913.USD","IE00B19Z9P08.USD","IDNA","KCE","CALF","LU2324357040.USD","LU0079474960.USD","LU1093756325.SGD","LU0234570918.USD","IE00B19Z3581.USD","IE0002270589.USD","LU0320765992.SGD","LU1035775433.USD","SGXZ57979304.SGD","VRTX","BK4532","LU2362540622.SGD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","IE00BJJMRZ35.SGD","LU2417539215.USD","BK4588","IE00B2B36J28.USD","LU0289739699.SGD","LU0061475181.USD","IBBQ","LU1069344957.HKD","IBB","LU0058720904.USD","BK4567","IE00B4R5TH58.HKD","BBH","IE00BZ9MQY76.HKD","LU0823416689.USD","LU1093756168.USD","LU1778281490.HKD","LU2462157665.USD","SG9999001176.USD","IE0009355771.USD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650131357","title":"吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2650131357","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650131357?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 00:16","pubTimestamp":1783700165,"startTime":"0","endTime":"0","summary":"• 吉利德科学股价在一项实体瘤三期临床试验失败后下跌。\n• 强劲的就业数据推高了美债收益率，令今日生物科技板块估值承压。\n• 由于肿瘤产品组合销售时间表推迟，分析师可能会下调其盈利预测。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262023383-market-movers-gild-20260710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU1934455863.HKD","BK4583","LU1674673428.USD","LU2112291526.USD","BK4585","LU0965509010.AUD","BK4568","LU0823416689.USD","BIB","LU0861579265.USD","LU1934455194.USD","LU1430594728.SGD","MEDI","BBH","GILD","IE00BZ1G4Q59.USD","LU0122379950.USD","BK4550","LU2087621335.USD","LU2468319806.SGD","IBBQ","BMED","IBB","SG9999015986.USD","IE00B3T34201.USD","LU1037948541.HKD","LU2324357040.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU0965509101.SGD","LU0289739699.SGD","LU1061106388.HKD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","LU1934455277.USD","IE00B19Z3B42.SGD","LU1674673691.USD","BK4566","LU0965509283.SGD","LU0889565916.HKD","LU1066053197.SGD","LU1057294990.SGD","BK4588","LU0882574055.USD","LU0058720904.USD","BK4578","BK4139","LU1571399168.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118208","title":"BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118208","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650118208?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 19:37","pubTimestamp":1783683425,"startTime":"0","endTime":"0","summary":".N** 费米公司FRMI.O：热点 - 因发行3.75亿美元可转换债券股价暴跌nL6N43C0K8** 吉利德科学公司GILD.O:** 礼来公司LLY.N:** 艾伯维公司ABBV.N:** 百健公司BIIB.O:热点 - 汇丰银行称生物制药并购交易有望创下年度新高nL4N43C0P3** 达美航空公司DAL.N:热点 - 因预测第三季度利润将超出预期，股价上涨nL4N43C0QQ** Circle Internet Group IncCRCL.N:热点 - 获最终监管批准在美国设立信托银行后股价上涨nL4N43C0SJ** SK海力士公司SKHY.O:热点 - 筹集265亿美元后，即将迎来备受期待的美国上市nL4N43C0TG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4S43C0TU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLII","LU0466842654.USD","LU0354030438.USD","LU0061475181.USD","BK4550","THNR","LU2468319806.SGD","LU2237438978.USD","LU0114720955.EUR","LU0345770308.USD","LU0689472784.USD","LU0708995401.HKD","LU0823434583.USD","LU0170899867.USD","IE00B1BXHZ80.USD","SG9999013999.USD","LU2129689431.USD","LU0203345920.USD","IE0004445015.USD","LU2491050071.SGD","IE0004445239.USD","LU0738911758.USD","LU0672654240.SGD","LU2471134523.USD","BK4532","LU1989772923.USD","LU0098860793.USD","LU1861217088.USD","LU2133065610.SGD","OZEM","FHLC","LU0868494708.USD","IXJ","IE00B7KXQ091.USD","LU1778281490.HKD","LU0708994859.HKD","IE00BFTCPJ56.SGD","BK4222","CRCD","IE00BJLML261.HKD","LU1868837136.USD","IE00BK4W5L77.USD","LU1804176565.USD","LU0097036916.USD","LU2237443549.SGD","IE00BLSP4239.USD","LU1571399168.USD","LU0553294199.USD","GB00BDT5M118.USD","LU2211815571.USD","LU0661504455.SGD","LU2462157665.USD","LU0266013472.USD","LU0511384066.AUD","BK4566","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU2461242641.AUD","LU2237443382.USD","LU0820561818.USD","LU2552382215.SGD","LU2746668461.USD","LU0689626769.HKD","LU2168564149.EUR","LU0106261372.USD","IE00BKDWB100.SGD","LU2756315664.SGD","LU1145028129.USD","LU2129689514.USD","IE000WAW04H5.SGD","LU1057294990.SGD","LU1061106388.HKD","LU0471298694.HKD","IE00B19Z9Z06.USD","LU1066053197.SGD","LU0289961442.SGD","LU1066051498.USD","LU1868836591.USD","WDNA","IYH","LU0203347892.USD","LU0964807845.USD","IE0001KFT4U8.USD","IE00B2B36J28.USD","CRCG","LU2360106947.USD","BK4599","MEDX","LU0889565916.HKD","LU2552382132.HKD","LU1868837300.USD","LU0256863811.USD","LU2168564065.EUR","BKCH","PJP","SGXZ31699556.SGD","IBB","LU1093756325.SGD","LU0861579265.USD","SG9999014880.SGD","LU1732799900.SGD","LU0820561909.HKD","LU1983299246.USD","LU0094547139.USD","IE00BKVL7J92.USD","LU1127390331.HKD","LU0882574139.USD","IE000BZT7R73.USD","LU2746668974.SGD","LU2023250330.USD","VHT","IE00BSNM7G36.USD","IE00BN29S564.USD","LU1035775433.USD","LU0238689110.USD","IE00BVYPNV92.GBP","LU1670628061.USD","SG9999003800.SGD","BK4583","IE00BGHQF631.EUR","LU0786609619.USD","ELIS","GILD","IE00B4R5TH58.HKD","SG9999015945.SGD","IE0005OL40V9.USD","BK4008","LU1989771016.USD","LU0949170772.SGD","LU0029864427.USD","IE000SO60NU8.SGD","LU0868494617.USD","LU2087621335.USD","LU2236285917.USD","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","SGXZ81514606.USD","BK4578","ILDR","LU0124676726.USD","BIB","SG9999017495.SGD","HRTS","LU0203202063.USD","ABBV","LU0211327993.USD","CCUP","LU2324357040.USD","IE00BLSP4452.SGD","LU0820562030.AUD","LU2089984988.USD","LU1718418525.SGD","IE0000B7K699.USD","LU0158827948.USD","LU0432979614.USD","LU1629891620.HKD","LU2111349929.HKD","SG9999018857.SGD","BK4568","PPH","LU1674673428.USD","LU1929549753.HKD","SG9999015952.SGD","BBH","LU1674673691.USD","LU0385154629.USD","LU2456880835.USD","BK4585","LU0198837287.USD","IE000F7OJYX1.SGD","SG9999014914.USD","IE00B19Z3B42.SGD","LU2491049909.HKD","LU2106854487.HKD","LU2417539215.USD","LU1496350171.SGD","PBE","LU1861220207.SGD","LU1989772840.SGD","FRMI","LU0471298777.SGD","LU1934455194.USD","LU1244550577.SGD","LU1548497426.USD","LU0323591593.USD","LU0256863902.USD","BK4559","IE00BWXC8680.SGD","SG9999018865.SGD","LU1551013425.SGD","SG9999015986.USD","IBBQ","LU0225283273.USD","SG9999014906.USD","ICRC","LU0345770993.USD","LU1232071149.USD","LU0109391861.USD","LU1670627923.USD","LU0128525689.USD","LU0683600562.USD","LU2237443622.USD","LU1732800096.USD","IE0002270589.USD","IE000MB6IJN5.SGD","LU2063271972.USD","IE00BBT3K403.USD","LU2264538146.SGD","LU2237443465.HKD","LU0234570918.USD","LU0079474960.USD","IE0009355771.USD","LU0787776722.HKD","LU0882574055.USD","LU1868836757.USD","LU2357305700.SGD","LU2471134952.CNY","CURE","BK4007","LU0640476718.USD","LU2552382058.USD","LU0316494557.USD","LU1496350502.SGD","IE00B775H168.HKD","IE00B42XCP33.USD","SGXZ99366536.SGD","LU0823416689.USD","LU1868836914.USD","IE00BVYPNW00.USD","LU2089284900.SGD","IE00BFSS7M15.SGD","LU2213496289.HKD","SG9999015978.USD","LU0965509010.AUD","IE00BN8TJ469.HKD","LU1934455863.HKD","GDOC","LU1093756168.USD","LU0128525929.USD","IBLC","LU0211328371.USD","LU0289739343.SGD","LU2750360997.AUD","LU0965509101.SGD","LU1267930490.SGD","LU1267930227.SGD","LU0354030511.USD","LU0069063385.USD","LU0234572021.USD","LU1668664300.SGD","BK4581","LU2023251221.USD","LU1244550221.USD","LU2347655156.SGD","LU2129689605.HKD","BK4500","LU0320765646.SGD","LU0985320562.USD","IE0002141913.USD","IHE","CRCL","IE00BJJMRZ35.SGD","LU0057025933.USD","LU1003077747.HKD","IE00BKPKM429.USD","BK4139","IE00BFSS8Q28.SGD","LU2756315318.SGD","SGXZ57979304.SGD","LU1430594728.SGD","LU2750360641.GBP","BK4534","LU0310799852.SGD","LU0310800379.SGD","LU1934455277.USD","LU1074936037.SGD","LU2361045086.USD","IE00B19Z9P08.USD","LU1720051017.SGD","LLY","LU0310800965.SGD","BK4588","LU0353189680.USD","LU2471134879.HKD","LU0210536198.USD","LU0203201768.USD","BK4516","IE00BDGV0183.EUR","FTXH","AGNG","IE00B3PB1722.GBP","DAL","LU1267930730.SGD","CRCA","LU1861558580.USD","LU1839511570.USD","LU2028103732.USD","ELIL","LU1037948897.HKD","LU0456855351.SGD","LU0122379950.USD","LU1244550494.USD","XLV","LU1291159041.SGD","LU2112291526.USD","SG9999001176.USD","LU0058720904.USD","LU2357627491.SGD","LU1974910355.USD","LU0823434740.USD","LU0006306889.USD","LU0158827781.USD","LU2168564495.EUR","IE00B894F039.SGD","SKHY","LU1861559042.SGD","LU0795875169.SGD","LU2089283258.USD","IE00B7SZLL34.SGD","LU2602419157.SGD","LU2168564222.USD","SG9999001176.SGD","LU1280957306.USD","LU2491050154.USD","LU0942090050.USD","LLYZ","LU0545039389.USD","LU1988902786.USD","LU0965508806.USD","LU0109394709.USD","IE00B3T34201.USD","IE00BK4W5M84.HKD","LU0106831901.USD","LU0417517546.SGD","LU1814569148.SGD","BK4533","LU1069344957.HKD","LU1323610961.USD","LU1551013342.USD","LU1162221912.USD","LU2271345857.HKD","LU2237443978.SGD","LU2361044865.SGD","SGXZ51526630.SGD","LU2896262040.SGD","MEDI","LU1585245621.USD","LU2237443895.HKD","LU0133085943.USD","IE00BFMHRM44.USD","JETS","LU2108987350.USD","IE00B4JS1V06.HKD","SKHYV","JDOC","LU1366192091.USD","LU2361044949.HKD","SG9999014898.SGD","RXL","LU2168563687.JPY","LU2360107671.USD","LLYX","LU0320765992.SGD","LU2023250504.SGD","LU0965509283.SGD","SG9999001440.SGD","LU1037948541.HKD","SG9999011175.SGD","LU1720051108.HKD","LU0052756011.USD","LU0353189763.USD","LU1064131342.USD","IE00BJT1NW94.SGD","BMED","LU0472753341.HKD","BK4023","BIIB","LU0943347566.SGD","LU1267930573.SGD","LU1712237335.SGD","LU0096364046.USD","LU0289739699.SGD","LU0320765059.SGD","CRCO","LU0795875086.SGD","CANC","LU0912757837.SGD","LU1791807156.HKD","LU0859254822.USD","LU2087625088.SGD","IE00B1XK9C88.USD","LU1623119135.USD","LU2265009873.SGD","LU1917777945.USD","LU2471134796.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650718438","title":"滙豐表示，生物製藥領域的併購交易有望創下年度新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2650718438","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650718438?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 18:33","pubTimestamp":1783679616,"startTime":"0","endTime":"0","summary":"BUZZ-汇丰表示，生物制药领域的并购交易有望创下年度新高7月10日-** 汇丰表示，生物制药领域的并购活动“正朝着创纪录的一年迈进”** 该券商指出，随着核心药品面临专利压力，大型制药企业正通过并购 (link) 来强化产品管线，并缓解对未来增长的担忧** 报告指出，截至4月，吉利德科学公司（GILD.O）在三笔收购中支付了约110亿美元的预付款；截至5月，礼来公司（LLY.N）的收购支出超过1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4T43C0Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU2646069778.SGD","LU1267930573.SGD","BIIB","PPH","ELIL","HRTS","NUVL","BMED","CURE","GILD","AGNG","LU1267930730.SGD","JDOC","BK5011","FTXH","LU0820561909.HKD","IBBQ","IYH","LLII","LU1934455277.USD","VHT","GSK.UK","LU0795875086.SGD","IBB","LU0786609619.USD","GDOC","LLYX","LU1804176565.USD","THNR","BBH","FHLC","ELIS","LLYZ","PBE","BIB","MEDX","OZEM","ILDR","WDNA","LU0683600562.USD","RXL","ABBV","IXJ","PJP","CANC","IHE","LU1323610961.USD","LLY","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913850","title":"福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913850","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650913850?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 02:15","pubTimestamp":1783534535,"startTime":"0","endTime":"0","summary":"• Vertex Pharmaceuticals已同意以100亿美元现金收购Crinetics Pharmaceuticals。\n• 此次收购溢价超过Crinetics股价的100%。\n• 在估值创历史新高期间，高管们根据预先安排的交易计划出售了公司股票。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262018348-market-movers-vrtx-20260708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","IE00BJJMRZ35.SGD","SG9999001176.USD","BIB","LU2324357040.USD","BBH","BK4585","BK4532","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0058720904.USD","IE0002270589.USD","LU2362541513.USD","LU1674673428.USD","BK4139","IE00BZ9MQY76.HKD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IDNA","LU0432979614.USD","LU1069344957.HKD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU0289739699.SGD","IE0002141913.USD","LU1035775433.USD","LU2362540622.SGD","VRTX","PBE","LU1674673691.USD","LU0079474960.USD","IBB","LU1430594728.SGD","IE00B19Z9Z06.USD","LU0889565916.HKD","LU1093756325.SGD","LU2417539215.USD","LU1585245621.USD","IBBQ","LU2362541273.HKD","LU2462157665.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU0234570918.USD","LU1093756168.USD","SG9999001176.SGD","LU1778281490.HKD","IE00B19Z9P08.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649299398","title":"大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649299398?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1720051108.HKD","IE0002141913.USD","IE00B894F039.SGD","LU2133065610.SGD","VRTX","IAI","LU0432979614.USD","BBH","LU2237438978.USD","BK4533","KBWB","LU0098860793.USD","BK4581","IE00BZ9MQY76.HKD","IE0002270589.USD","LU0058720904.USD","LU1585245621.USD","IDNA","IE0009355771.USD","IE00B19Z3581.USD","LU2487616109.SGD","LU0390134368.USD","LU2456880835.USD","LU1244550221.USD","LU0528227936.USD","IBB","PBE","LU0079474960.USD","BIB","LU0882574139.USD","LU2111349929.HKD","BK4588","LU0053666078.USD","LU0267386448.USD","LU0823416689.USD","LU1732799900.SGD","BK4139","SG9999001176.USD","LU0210528500.USD","IBBQ","LU2362541273.HKD","LU1363072403.SGD","LU0109394709.USD","LU1674673691.USD","LU2089284900.SGD","LU1720051017.SGD","LU2362540622.SGD","LU2236285917.USD","IE00B19Z9P08.USD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649964779","title":"復宏漢霖(02696)：西妥昔單抗注射液生物類似藥HLX05-N在轉移性結直腸癌(mCRC)患者中的1期臨床研究於中國境內完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2649964779","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649964779?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 17:27","pubTimestamp":1783502848,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖 发布公告，近日，本公司自主研发的西妥昔单抗注射液生物类似药HLX05-N在转移性结直肠癌患者中的1期临床研究于中国境内完成首例患者给药。本研究是一项在KRAS/NRAS野生型且BRAF V600E无突变的转移性结直肠癌参与者中，比较HLX05-N与美国及欧盟来源Erbitux联合化疗 治疗的多中心、随机、双盲、平行对照1期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PPH","HK0000320223.HKD","LU2272731865.HKD","HK0000165453.HKD","BK4585","02696","IBB","HK0000306701.USD","BK4588","BK1161","XPH","HK0000320264.USD","LU2322448957.HKD","IE00B5TLWC47.USD","LU1992135472.HKD","LU2272731782.SGD","HK0000306685.HKD","LU1992135399.USD","LU2272731600.USD","LU2473716301.USD","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上調福泰製藥目標價至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649969921?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2324357040.USD","IE00B894F039.SGD","VRTX","BBH","LU1778281490.HKD","IE00B19Z3B42.SGD","LU2237438978.USD","BK4533","IE00B4R5TH58.HKD","LU0708994859.HKD","SG9999013999.USD","BK4585","LU0058720904.USD","IDNA","LU0128525929.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU2462157665.USD","IBB","LU1093756325.SGD","GSIB","PBE","UDN","BIB","LU1093756168.USD","LU0823416689.USD","BK4532","LU2417539215.USD","LU0234570918.USD","BK4207","BK4139","LU0029864427.USD","SG9999001176.USD","IBBQ","LU1267930573.SGD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU2362540622.SGD","LU0310800379.SGD","BK4567","LU0289739699.SGD","LU0320765992.SGD","IE00B19Z9P08.USD","UUP","RY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}